Literature DB >> 27569041

The challenge of rapid diagnosis in oncology: Diagnostic accuracy and cost analysis of a large-scale one-stop breast clinic.

Suzette Delaloge1, Julia Bonastre2, Isabelle Borget2, Jean-Rémi Garbay3, Rachel Fontenay2, Diane Boinon4, Mahasti Saghatchian5, Marie-Christine Mathieu6, Chafika Mazouni3, Sofia Rivera7, Catherine Uzan3, Fabrice André5, Clarisse Dromain8, Bruno Boyer8, Barbara Pistilli5, Sandy Azoulay6, Françoise Rimareix3, El-Hadi Bayou8, Benjamin Sarfati3, Hélène Caron5, Amal Ghouadni5, Nicolas Leymarie3, Sandra Canale8, Muriel Mons9, Julia Arfi-Rouche8, Monica Arnedos5, Voichita Suciu6, Philippe Vielh6, Corinne Balleyguier8.   

Abstract

PURPOSE: Rapid diagnosis is a key issue in modern oncology, for which one-stop breast clinics are a model. We aimed to assess the diagnosis accuracy and procedure costs of a large-scale one-stop breast clinic. PATIENTS AND METHODS: A total of 10,602 individuals with suspect breast lesions attended the Gustave Roussy's regional one-stop breast clinic between 2004 and 2012. The multidisciplinary clinic uses multimodal imaging together with ultrasonography-guided fine needle aspiration for masses and ultrasonography-guided and stereotactic biopsies as needed. Diagnostic accuracy was assessed by comparing one-stop diagnosis to the consolidated diagnosis obtained after surgery or biopsy or long-term monitoring. The medical cost per patient of the care pathway was assessed from patient-level data collected prospectively.
RESULTS: Sixty-nine percent of the patients had masses, while 31% had micro-calcifications or other non-mass lesions. In 75% of the cases (87% of masses), an exact diagnosis could be given on the same day. In the base-case analysis (i.e. considering only benign and malignant lesions at one-stop and at consolidated diagnoses), the sensitivity of the one-stop clinic was 98.4%, specificity 99.8%, positive and negative predictive values 99.7% and 99.0%. In the sensitivity analysis (reclassification of suspect, atypical and undetermined lesions), diagnostic sensitivity varied from 90.3% to 98.5% and specificity varied from 94.3% to 99.8%. The mean medical cost per patient of one-stop diagnostic procedure was €420.
CONCLUSIONS: One-stop breast clinic can provide timely and cost-efficient delivery of highly accurate diagnoses and serve as models of care for multiple settings, including rapid screening-linked diagnosis.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Breast cancer; Cost analysis; Diagnosis; One-stop clinic; Sensitivity; Specificity

Mesh:

Year:  2016        PMID: 27569041     DOI: 10.1016/j.ejca.2016.06.021

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  7 in total

1.  Preclinical ex vivo evaluation of the diagnostic performance of a new device for in situ label-free fluorescence spectral analysis of breast masses.

Authors:  Marie-Christine Mathieu; Alexis Toullec; Charlotte Benoit; Richard Berry; Pierre Validire; Pauline Beaumel; Yves Vincent; Pierre Maroun; Philippe Vielh; Lama Alchab; René Farcy; Hélène Moniz-Koum; Marie-Pierre Fontaine-Aupart; Suzette Delaloge; Corinne Balleyguier
Journal:  Eur Radiol       Date:  2018-01-05       Impact factor: 5.315

2.  Improving waiting times in the orthopaedic outpatient clinic.

Authors:  Julia Street; Wajeeha Khan; Aureola Tong; Vasudev Shanbhag
Journal:  BMJ Open Qual       Date:  2017-08-09

3.  Image-guided breast biopsy and localisation: recommendations for information to women and referring physicians by the European Society of Breast Imaging.

Authors:  Ulrich Bick; Rubina M Trimboli; Alexandra Athanasiou; Corinne Balleyguier; Pascal A T Baltzer; Maria Bernathova; Krisztina Borbély; Boris Brkljacic; Luca A Carbonaro; Paola Clauser; Enrico Cassano; Catherine Colin; Gul Esen; Andrew Evans; Eva M Fallenberg; Michael H Fuchsjaeger; Fiona J Gilbert; Thomas H Helbich; Sylvia H Heywang-Köbrunner; Michel Herranz; Karen Kinkel; Fleur Kilburn-Toppin; Christiane K Kuhl; Mihai Lesaru; Marc B I Lobbes; Ritse M Mann; Laura Martincich; Pietro Panizza; Federica Pediconi; Ruud M Pijnappel; Katja Pinker; Simone Schiaffino; Tamar Sella; Isabelle Thomassin-Naggara; Anne Tardivon; Chantal Van Ongeval; Matthew G Wallis; Sophia Zackrisson; Gabor Forrai; Julia Camps Herrero; Francesco Sardanelli
Journal:  Insights Imaging       Date:  2020-02-05

4.  Accelerated Tissue Processing With Minimal Formalin Fixation Time for 9-Gauge Vacuum-Assisted Breast Biopsy Specimens.

Authors:  Joris P Bulte; Altuna Halilovic; Lambert J M Burgers; Coos J M Diepenbroek; Robin A K de la Roij; Ritse M Mann; Marloes van der Leest; Patricia H J van Cleef; Luc J A Strobbe; Johannes H W de Wilt; Peter Bult
Journal:  Am J Clin Pathol       Date:  2020-01-01       Impact factor: 2.493

5.  The symptomatic breast services in a university hospital: pandemic peak compared to the pre-pandemic year and future implications.

Authors:  Gaurav Jyoti Bansal; Zara Saleem
Journal:  Ir J Med Sci       Date:  2022-01-05       Impact factor: 2.089

Review 6.  Importance of Cytopathologic Diagnosis in Early Cancer Diagnosis in Resource-Constrained Countries.

Authors:  Kavita Yadav; Ian Cree; Andrew Field; Philippe Vielh; Ravi Mehrotra
Journal:  JCO Glob Oncol       Date:  2022-02

7.  "One stop" clinic for upper gastrointestinal cancer-an alternative to "straight to test" referrals?

Authors:  Marina Yiasemidou; Ross Lathan; Manfred Lambertz; Chitakattil Oommen; Ian Chetter
Journal:  Ir J Med Sci       Date:  2021-07-20       Impact factor: 1.568

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.